Gain Therapeutics is trading at $1.26, up 5.88%, with no clear catalyst identified. - Its latest listed company announcements were dated October 8 and October 1, not October 22. - The Fly listed a BTIG price-target reduction on October 22, but available reporting does not explain the change or establish a reason for the gain. - Broader markets were sharply lower, so the supplied market context does not explain the rise.